Merck (NYSE:MRK) has committed to implementing Veeva Systems’ (NYSE:VEEV) Vault CRM solution, according to a press release issued Monday. The pharmaceutical company will use the customer relationship management platform to support what it describes as one of the most significant launch periods in its history across multiple therapeutic areas.
The agreement expands the existing strategic partnership between the two companies. Vault CRM is part of Veeva’s suite of applications designed for commercial execution across personal and digital channels in the life sciences industry.
"Vault CRM will provide Merck the technology foundation to drive commercial execution," said Dave Williams, executive vice president and chief information and digital officer at Merck, in the statement.
Peter Gassner, Veeva CEO, expressed appreciation for the expanded partnership with Merck, which is known as MSD outside the United States and Canada.
The Vault CRM Suite includes capabilities to address region-specific business and compliance requirements for global pharmaceutical companies.
The announcement comes as Merck prepares for multiple product launches across diverse therapeutic areas and treatment modalities. The press release did not specify which products are scheduled for launch or provide a timeline for the implementation of the new CRM system.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.